T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Saic
SAIC
$5.34B
| $4.14M | ﹤0.01% |
29,697
-1,665
| -5% | -$210K |
|
1352
MacroGenics
MGNX
$247M
| $4.13M | ﹤0.01% |
1,254,236
-82,784
| -6% | -$323K |
|
1353
Wyndham Hotels & Resorts
WH
$5.48B
| $4.13M | ﹤0.01% |
52,808
+2,211
| +4% | +$168K |
|
1354
Matsons
MATX
$6.48B
| $4.12M | ﹤0.01% |
28,856
+703
| +2% | +$92.5K |
|
1355
Brady Corp
BRC
$4.4B
| $4.09M | ﹤0.01% |
53,388
-634
| -1% | -$45.1K |
|
1356
Gentex
GNTX
$4.99B
| $4.09M | ﹤0.01% |
137,729
+6,903
| +5% | +$214K |
|
1357
Glacier Bancorp
GBCI
$6.51B
| $4.07M | ﹤0.01% |
88,913
+3,632
| +4% | +$157K |
|
1358
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $4.06M | ﹤0.01% |
30,708
| – | – |
|
1359
Glaukos
GKOS
$11.1B
| $4.03M | ﹤0.01% |
30,955
-1,681
| -5% | -$209K |
|
1360
Coca-Cola Europacific Partners
CCEP
$47.7B
| $4.03M | ﹤0.01% |
51,169
+4,531
| +10% | +$347K |
|
1361
Prosperity Bancshares
PB
$9B
| $4.02M | ﹤0.01% |
55,774
+3,698
| +7% | +$258K |
|
1362
WSFS Financial
WSFS
$4.18B
| $3.98M | ﹤0.01% |
78,151
-124,438
| -61% | -$6.45M |
|
1363
Flywire
FLYW
$2.26B
| $3.98M | ﹤0.01% |
242,717
-496,851
| -67% | -$8.68M |
|
1364
HF Sinclair
DINO
$16.4B
| $3.97M | ﹤0.01% |
89,055
+6,099
| +7% | +$291K |
|
1365
Viking Therapeutics
VKTX
$3.82B
| $3.97M | ﹤0.01% |
62,669
+2,999
| +5% | +$176K |
|
1366
Commerce Bancshares
CBSH
$8.66B
| $3.96M | ﹤0.01% |
73,581
+1,954
| +3% | +$108K |
|
1367
Dole
DOLE
$1.26B
| $3.96M | ﹤0.01% |
243,126
+29,867
| +14% | +$446K |
|
1368
Travere Therapeutics
TVTX
$5.78B
| $3.94M | ﹤0.01% |
281,349
+247,908
| +741% | +$2.58M |
|
1369
Kite Realty
KRG
$5.33B
| $3.91M | ﹤0.01% |
147,315
+2,218
| +2% | +$55K |
|
1370
SEI Investments
SEIC
$12.8B
| $3.9M | ﹤0.01% |
56,422
+2,988
| +6% | +$199K |
|
1371
Thor Industries
THO
$4.1B
| $3.9M | ﹤0.01% |
35,464
+1,730
| +5% | +$176K |
|
1372
Arcosa
ACA
$7.14B
| $3.84M | ﹤0.01% |
40,517
+90
| +0.2% | +$7.86K |
|
1373
Wintrust Financial
WTFC
$11B
| $3.83M | ﹤0.01% |
35,247
+5,868
| +20% | +$612K |
|
1374
Zentalis Pharmaceuticals
ZNTL
$257M
| $3.82M | ﹤0.01% |
1,036,911
+113,010
| +12% | +$411K |
|
1375
Alector
ALEC
$228M
| $3.81M | ﹤0.01% |
816,458
-53,120
| -6% | -$285K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.